Five Companies With Rising Earnings Expectations
Insurance earnings estimates are improving
TWFG has seen a notable increase in current-year earnings expectations, suggesting improving profit fundamentals.
| Instrument | Side | Target | Reason |
|---|---|---|---|
| TWFG | Long | Current-year earnings expectations have risen 9.7% over 60 days, pointing to improving operating momentum in the insurance business. |
Freight transportation outlook is strengthening
XPO benefits from rising earnings expectations, indicating a better profit outlook for its freight transportation services.
| Instrument | Side | Target | Reason |
|---|---|---|---|
| XPO | Long | Current-year earnings expectations have increased 8% over 60 days, supporting a constructive view on freight transportation profitability. |
Fuel retail earnings outlook has improved sharply
Murphy USA shows strong upward earnings revisions, signaling improved expectations for its retail fuel marketing business.
| Instrument | Side | Target | Reason |
|---|---|---|---|
| MUSA | Long | Current-year earnings expectations have risen 26.7% over 60 days, indicating a materially stronger profit outlook for the fuel retail business. |
Payment software earnings expectations surge
Flywire has experienced a very large upward revision in current-year earnings expectations, suggesting accelerating profitability.
| Instrument | Side | Target | Reason |
|---|---|---|---|
| FLYW | Long | Current-year earnings expectations have increased 236.7% over 60 days, pointing to a sharply improving profitability outlook for the payments and software platform. |
Biopharma profit expectations move higher
Kiniksa Pharmaceuticals has seen rising earnings expectations, suggesting improving fundamentals in its biopharmaceutical business.
| Instrument | Side | Target | Reason |
|---|---|---|---|
| KNSA | Long | Current-year earnings expectations have risen 13.8% over 60 days, supporting a more favorable view of the company’s biopharmaceutical fundamentals. |
Themes
The content on this page is for informational purposes only and does not constitute financial advice. Stoquate is not a licensed financial advisor. Always conduct your own research and consult a qualified professional before making any investment decisions.